The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
Uterine Cancer (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Uterine Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Uterine Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Uterine Cancer pipeline landscape. The report provides...
April 2021
110 pages
Von Willebrand Factor (VWF) - Drugs in Development, 2021
US$ 3,000.00
Von Willebrand Factor (VWF) - Drugs in Development, 2021 SUMMARY Von Willebrand Factor (VWF) - Drugs in Development, 2021 provides in depth analysis on Von Willebrand Factor (VWF) targeted pipeline th...
April 2021
35 pages
Vulvar Cancer (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Vulvar Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Vulvar Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Vulvar Cancer pipeline landscape. The report provides co...
April 2021
80 pages
Wnt Protein (WNT) - Drugs in Development, 2021
US$ 3,000.00
Wnt Protein (WNT) - Drugs in Development, 2021 SUMMARY Wnt Protein (WNT) - Drugs in Development, 2021 provides in depth analysis on Wnt Protein (WNT) targeted pipeline therapeutics. The report provide...
April 2021
35 pages
Investigation Report on China's Ibrutinib Market 2021-2025
US$ 2,600.00
Ibrutinib is a BTK inhibitor, mainly used to treat B-cell carcinomas, such as mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstrom's macroglobulinemia. Ibrutinib was first developed by...
April 2021
40 pages
